PRSS56 and microphthalmia: Consistent with ocular findings in Prss56-/- mice, the human PRSS56 mutation led to a substantial reduction in VCD compared to a normal emmetropic eye (Fig 1H and 1I and Table 1), suggesting that PRSS56 mutations leading to nanophthalmos and extreme hyperopia in humans likely act via a loss of function mechanism.